Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Aiginger

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Neurology|January 1, 1986
CSF cytology of a patient with conversion of an acute lymphatic leukemia to an acute eosinophilic leukemiaH Kollegger, P Preis, E Maida, et al.
Urological Research|January 1, 1989
HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testisC Kratzik, P Aiginger, R Kuzmits, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Influence of cytostatics on ATP-levels of leukemic cellsR Kuzmits, P Aiginger, M Frass, et al.
Lancet (London, England)|January 31, 1987
HLA antigens and germ-cell tumoursP Aiginger, R Kuzmits, C Kratzig, et al.
Lancet (London, England)|November 15, 1986
Adjuvant chemotherapy combined with tamoxifen in postmenopausal patients with stage II breast cancerC C Zielinski, E Kubista, H Salzer, et al.
Wiener Klinische Wochenschrift|May 13, 1988
Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case reportP P Preis, C C Zielinski, W Linkesch, et al.
Cancer|August 15, 1991
Risk factors for bilateral testicular germ cell tumors. Does heredity play a role?C Kratzik, P Aiginger, W Kuber, et al.
Lancet (London, England)|March 3, 1990
Adjuvant tamoxifen in postmenopausal stage II breast cancer five years onJ Mikl, P Aiginger, K Czerwenka, et al.
Blut|May 1, 1985
CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosisR Heinz, E Neumann, P Aiginger, et al.
Wiener Medizinische Wochenschrift (1946)|June 15, 1984
[Treatment of breast cancer at the 1st Gynecology Clinic at the University of Vienna]E Kubista, H Salzer, F Fischl, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Neurology|January 1, 1986
CSF cytology of a patient with conversion of an acute lymphatic leukemia to an acute eosinophilic leukemiaH Kollegger, P Preis, E Maida, et al.
Urological Research|January 1, 1989
HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testisC Kratzik, P Aiginger, R Kuzmits, et al.
Advances in Experimental Medicine and Biology|January 1, 1984
Influence of cytostatics on ATP-levels of leukemic cellsR Kuzmits, P Aiginger, M Frass, et al.
Lancet (London, England)|January 31, 1987
HLA antigens and germ-cell tumoursP Aiginger, R Kuzmits, C Kratzig, et al.
Lancet (London, England)|November 15, 1986
Adjuvant chemotherapy combined with tamoxifen in postmenopausal patients with stage II breast cancerC C Zielinski, E Kubista, H Salzer, et al.
Wiener Klinische Wochenschrift|May 13, 1988
Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case reportP P Preis, C C Zielinski, W Linkesch, et al.
Cancer|August 15, 1991
Risk factors for bilateral testicular germ cell tumors. Does heredity play a role?C Kratzik, P Aiginger, W Kuber, et al.
Lancet (London, England)|March 3, 1990
Adjuvant tamoxifen in postmenopausal stage II breast cancer five years onJ Mikl, P Aiginger, K Czerwenka, et al.
Blut|May 1, 1985
CHOP-firstline treatment in NHL with unfavorable prognosis--evaluation of therapeutic response and factors influencing prognosisR Heinz, E Neumann, P Aiginger, et al.
Wiener Medizinische Wochenschrift (1946)|June 15, 1984
[Treatment of breast cancer at the 1st Gynecology Clinic at the University of Vienna]E Kubista, H Salzer, F Fischl, et al.
Pageof 6